Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Dupuis

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Anti-Cancer Drugs|November 16, 2013
Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cellsMark E Issa, Steven R Hall, Stephanie N Dupuis, et al.
The European Respiratory Journal|July 3, 2025
Risk of rifampicin resistance emergence after incomplete first-line tuberculosis treatmentGenevieve N Dupuis, Mariia Dolynska, Silvia S Chiang, et al.
BMC Public Health|January 31, 2024
The role of self-efficacy in women's autonomy for health and nutrition decision-making in rural BangladeshAllison P Salinger, Ellen Vermes, Jillian L Waid, et al.
Journal of Natural Products|November 5, 2011
Jadomycins derived from the assimilation and incorporation of norvaline and norleucineStephanie N Dupuis, Thomas Veinot, Susan M A Monro, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2020
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancerA Martinez, M Voglimacci, A Lusque, et al.
Optics Express|June 12, 2008
A hybrid electroabsorption modulator device for generation of high spectral-efficiency optical modulation formatsI Kang, S Chandrasekhar, L Buhl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancerE E W Cohen, L F Licitra, B Burtness, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Anti-Cancer Drugs|November 16, 2013
Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cellsMark E Issa, Steven R Hall, Stephanie N Dupuis, et al.
The European Respiratory Journal|July 3, 2025
Risk of rifampicin resistance emergence after incomplete first-line tuberculosis treatmentGenevieve N Dupuis, Mariia Dolynska, Silvia S Chiang, et al.
BMC Public Health|January 31, 2024
The role of self-efficacy in women's autonomy for health and nutrition decision-making in rural BangladeshAllison P Salinger, Ellen Vermes, Jillian L Waid, et al.
Journal of Natural Products|November 5, 2011
Jadomycins derived from the assimilation and incorporation of norvaline and norleucineStephanie N Dupuis, Thomas Veinot, Susan M A Monro, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2020
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancerA Martinez, M Voglimacci, A Lusque, et al.
Optics Express|June 12, 2008
A hybrid electroabsorption modulator device for generation of high spectral-efficiency optical modulation formatsI Kang, S Chandrasekhar, L Buhl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancerE E W Cohen, L F Licitra, B Burtness, et al.
Pageof 4